300 related articles for article (PubMed ID: 21956922)
1. Molecular alterations during progression of prostate cancer to androgen independence.
Saraon P; Jarvi K; Diamandis EP
Clin Chem; 2011 Oct; 57(10):1366-75. PubMed ID: 21956922
[TBL] [Abstract][Full Text] [Related]
2. Drug insight: role of the androgen receptor in the development and progression of prostate cancer.
Taplin ME
Nat Clin Pract Oncol; 2007 Apr; 4(4):236-44. PubMed ID: 17392714
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.
Taplin ME; Balk SP
J Cell Biochem; 2004 Feb; 91(3):483-90. PubMed ID: 14755679
[TBL] [Abstract][Full Text] [Related]
4. The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer.
Kageyama Y; Hyochi N; Kihara K; Sugiyama H
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):203-11. PubMed ID: 18221063
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer.
Nguyen MM; Wang Z
Minerva Urol Nefrol; 2008 Mar; 60(1):15-29. PubMed ID: 18427432
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor: role and novel therapeutic prospects in prostate cancer.
Taplin ME
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1495-508. PubMed ID: 18759700
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Androgen-Independent Prostate Cancer.
Saraon P; Drabovich AP; Jarvi KA; Diamandis EP
EJIFCC; 2014 Apr; 25(1):42-54. PubMed ID: 27683456
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor as a target in androgen-independent prostate cancer.
Balk SP
Urology; 2002 Sep; 60(3 Suppl 1):132-8; discussion 138-9. PubMed ID: 12231070
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway.
Mellado B; Codony J; Ribal MJ; Visa L; Gascón P
Clin Transl Oncol; 2009 Jan; 11(1):5-10. PubMed ID: 19155198
[TBL] [Abstract][Full Text] [Related]
10. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of castration-resistant prostate cancer: basis for the novel therapeutic targets.
Mellado B; Marin Aguilera M; Pereira MV
Arch Esp Urol; 2013 Jun; 66(5):453-62. PubMed ID: 23793763
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding hormonal therapy resistant prostate cancer.
Donkena KV; Yuan H; Young CY
Curr Cancer Drug Targets; 2010 Jun; 10(4):402-10. PubMed ID: 20464780
[TBL] [Abstract][Full Text] [Related]
13. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer.
Wang G; Sadar MD
J Cell Biochem; 2006 May; 98(1):36-53. PubMed ID: 16440300
[TBL] [Abstract][Full Text] [Related]
15. Alterations of androgen receptor in prostate cancer.
Linja MJ; Visakorpi T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):255-64. PubMed ID: 15663988
[TBL] [Abstract][Full Text] [Related]
16. The androgen receptor: genetic considerations in the development and treatment of prostate cancer.
Cude KJ; Dixon SC; Guo Y; Lisella J; Figg WD
J Mol Med (Berl); 1999 May; 77(5):419-26. PubMed ID: 10426191
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of prostate cancer progression to androgen independence.
McPhaul MJ
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):373-88. PubMed ID: 18471793
[TBL] [Abstract][Full Text] [Related]
18. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
[TBL] [Abstract][Full Text] [Related]
19. Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer.
Fernandes RC; Hickey TE; Tilley WD; Selth LA
Endocr Relat Cancer; 2019 May; 26(5):R237-R257. PubMed ID: 30817318
[TBL] [Abstract][Full Text] [Related]
20. Hormone treatment for prostate cancer: current issues and future directions.
Ichikawa T; Suzuki H; Ueda T; Komiya A; Imamoto T; Kojima S
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():58-63. PubMed ID: 16273367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
